Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) EV/FCF
As of 5 November 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/FCF of 24.6×. Over the past ten years it has ranged from 21.2× (December 2018) to 142× (April 2021); the current reading is higher than 13% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 23.0× | (33.78%) |
| FY2024 | 34.7× | (1.11%) |
| FY2023 | 35.1× | (4.49%) |
| FY2022 | 36.7× | 9.84% |
| FY2021 | 33.4× | (56.16%) |
| FY2020 | 76.2× | 63.84% |
| FY2019 | 46.5× | 109.12% |
| FY2018 | 22.2× | (29.13%) |
| FY2017 | 31.4× | 12.01% |
| FY2016 | 28.0× | (59.50%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 21.5× | (5.52%) |
| Jun 2026 | 22.8× | (6.93%) |
| Mar 2026 | 24.5× | 6.64% |
| Dec 2025 | 23.0× | (11.84%) |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 8.3× |
| GMED Globus Medical, Inc. compare | 14.9× |
| PHG Koninklijke Philips N.V. compare | 16.3× |
| ZBH Zimmer Biomet Holdings, Inc. | 24.6× |
| STE STERIS plc compare | 27.8× |
| DXCM DexCom, Inc. compare | 29.0× |
| PODD Insulet Corporation compare | 48.0× |
| PEN Penumbra, Inc. compare | 59.8× |
| GKOS Glaukos Corporation compare | 360× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement